Artificial intelligence for the diagnosis and prognosis of leprosy, leishmaniasis, and schistosomiasis: A systematic review

Authors:

Abstract
Background: Neglected Tropical Diseases affect over one billion individuals globally, challenging healthcare systems in endemic regions. While promising, Artificial Intelligence (AI) requires rigorous validation for clinical translation. Methodology: This systematic review of prediction-model studies evaluated AI applications for leprosy, schistosomiasis, and leishmaniasis (2015–2025). Methodological quality and reporting transparency of the included studies were appraised using the PROBAST+AI and TRIPOD+AI tools, respectively. Findings: Among 69 studies identified, 89.9% were published after 2020. The literature predominantly focused on diagnostic support (81.2%), leaving the prognosis of adverse outcomes underexplored (18.8%). Methodological fragility was widely observed: 89.9% of models exhibited a high risk of bias, primarily due to lack of external validation (82.6%) and failure to report or appropriately handle missing data (66.7%). Transparency remains a barrier, with source code unavailable in 76.8% of cases, hindering reproducibility. Conclusion: Current evidence indicates that quantitative output outpaces methodological maturity. Bridging the gap between algorithmic potential and public health impact requires prioritizing open science and robust validation.
Funding Information
  • Fundação de Amparo à Pesquisa do Estado de São Paulo (2025/13189-1)
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico (409782/2025-4)

This publication has 28 references indexed in Scilit: